Clinical Trial Update: Shockwave Lithoplasty DISRUPT Trial for PAD (DISRUPT PAD 2) [NA]

View source ↗

Summary

The DISRUPT PAD 2 trial evaluating the Shockwave Lithoplasty system for peripheral arterial disease has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Shockwave Lithoplasty System

Snippet

Sponsor: Shockwave Medical, Inc. | Conditions: Peripheral Arterial Disease | NA | Status: COMPLETED | Results posted: 2018-04-18